Improving Eligibility Classification on Clinical Trials Document using Bidirectional Long Short Term Memory Recurrent Neural Network
Main Article Content
Abstract
Cancer clinical trials intervention are generally too restrictive, and some patients are often excluded on the basis of
comorbidity, past or concomitant treatments, or the fact that they are over a certain age. In this research we built a
classification model for clinical information using public clinical trial protocols labeled as eligible or not eligible. Text
classifications are trained using deep learning to determine the predictive outcome of short free text statements
reflectingeligible and not eligible clinical information.then we also performed semantic analysis for the obtained wordembedding
representations and were able to identify similar treatments. We have proven that learning outcomes using deep
learning methods to extract medical information from clinical trial documents have been successful in assisting health
practitioners in prescribing treatments. The evaluation results showed a value with an accuracy value is 77.74%, precision is
76.8%, recall is 80.80%, and F1-score is 78.80%
Downloads
Metrics
Article Details
Licensing
TURCOMAT publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
